Fermer le menu

 

Member of Lyonbiopole

 

Development of innovative therapies for the treatment of resistant cancers by targeting Aldehyde Dehydrogenases.

 

Strategic application domain: Human Medicine

Application market: Oncology

Type of activity: CRO - Tools - R&D platform, Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Molecular Biology & Nucleic acid, Small Molecules

Created on aug. 2nd, 2010 - 25 employees

 

Address

Parc Technologique de Lyon - 655, Allée des Parcs - Bâtiment D - 69800 Saint Priest - France 69800 St Priest

 

Contacts

Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.

R&D projects